eBook

Everyone's a Scout

The opportunities, the challenges, the solution.

In the pursuit of their next breakthrough, life science companies have transformed their development process, combining their in-house expertise with scouting for external innovation.
But to find the best opportunities before their competition, everyone must be a scout. While this approach brings significant advantages, it also creates new challenges.

Download the ebook

Inova_Everyone is a Scout-page2
Inova_Everyone is a Scout-page11
Inova_Everyone is a Scout-page14
Preview eBook

Embracing the “everyone is a scout” approach, we discuss how the industry got here, who does it well, key challenges to overcome, and how to make it happen.

  • Rise of the Biotechs.A half century ago, the world’s pharma giants were competing purely on science. Today, they're also fighting for the right partners.
  • Tales of Success: The seeds of successful collaboration can be found in the most unlikely places.
  • The Challenges. To make the "everyone is a scout" approach work, key challenges must be confronted and overcome.

Resources you may be interested in

Partnering 2030_ The Biotech Perspective

Partnering 2030: The Biotech Perspective

Download whitepaper
DueDiligence-Pharma-leaders-thumbnail-image

Due Diligence Best Practices from Pharma Leaders

Download whitepaper
What Reporting Data are Top Pharma R&D and BD Teams Tracking - Banners_Linkedin

What Reporting Data are Top Pharma Tracking?

Download whitepaper

About Inova

Inova accelerates partnering for the future of medicine. Our cloud-based solutions help life science companies manage their biopharma opportunities more efficiently. They find all their partnering information in one place, track their deals and alliances easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from the 20 biggest biopharma events automatically available in Inova, providing our users with always up-to-date company and contact information. Over 160 life science companies, including 60% of the top 50 pharmaceutical companies and many midsize pharma and innovative biotechs already use Inova.